Beyond cancer, ongoing research is exploring the potential of these medications in treating a wide range of conditions. Early data suggest they may help delay the onset of Alzheimer’s disease, improve outcomes in obstructive sleep apnea, reduce alcohol cravings, treat liver disease, and address various other metabolic and neurological disorders. As our understanding of metabolic health deepens, drugs like tirzepatide may prove to be transformative—not just for obesity, but for the broader landscape of chronic disease management.
